The Dexamethasone Sodium Phosphate I, cataloged under National Stock Number 6505-01-344-3990, is classified within Federal Supply Class 6505 (No Item Name Available) of the Medical, Dental, and Veterinary Equipment group. The primary manufacturer of record is Lyphomed Inc Div of Fujisawa Usa Inc. Government technical data includes 5 verified specifications, sourced from the Federal Logistics Information System (FLIS). This item has 2 commercial cross-references from 1 manufacturer, enabling identification through both NSN and commercial part number lookups. 7 verified substitutes exist in the FLIS interchangeability database. Current acquisition status: Active.
| Parameter | Value |
|---|---|
| NSN | 6505-01-344-3990 |
| Primary Part Number | NDC00469-1650-20 |
| Item Name | Dexamethasone Sodium Phosphate I |
| FSC / FSG | 6505 / 65 — No Item Name Available |
| Manufacturer | Lyphomed Inc Div of Fujisawa Usa Inc |
| Status | ACTIVE |
| Total Primary Container Quantity | 25 |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Primary Container Content Quantity | 5.000 MILLILITERS |
| Primary Container Type | VIAL, MULTIPLE DOSE |
| Active Medicament Medicinal Strength | 4.000 MILLIGRAMS DEXAMETHASONE SODIUM PHOSPHATE EQUIVALENT PER MILLILITER AND 1.500 MILLIGRAMS SODIUM SULFITE EQUIVALENT PER MILLILITER AND 10.000 MILLIGRAMS DEXAMETHASONE PHOSPHATE EQUIVALENT |
| Acquisition Status | ACTIVE |
| HAZMAT | No |
| Part Number | Manufacturer |
|---|---|
| NDC00469-1650-20 | Lyphomed Inc Div of Fujisawa Usa Inc (USA) |
| 16505 | Lyphomed Inc Div of Fujisawa Usa Inc (USA) |
NSN 6505-01-344-3990 is a Dexamethasone Sodium Phosphate I, manufactured by Lyphomed Inc Div of Fujisawa Usa Inc, classified under FSC 6505 (No Item Name Available). Status: active.
NSN 6505-01-344-3990 has 2 cross-referenced part numbers: NDC00469-1650-20 (Lyphomed Inc Div of Fujisawa Usa Inc), 16505 (Lyphomed Inc Div of Fujisawa Usa Inc).
There are 7 known substitutes for 6505-01-344-3990: 4240-00-300-6967, 5920-01-149-9487, 5310-01-173-3366 and 4 more. Verify interchangeability with system specifications before substitution.
Key specifications for NDC00469-1650-20: Total Primary Container Quantity: 25; Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Special Features: EACH ML. CONTAINS 0.9% BENZYL ALCOHOL; Q.S. WATER FOR INJECTION; MADE ISOTONIC WITH SODIUM CITRATE; Primary Container Content Quantity: 5.000 MILLILITERS. 6 total characteristics are documented in the Federal Logistics Information System.